X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (133) 133
clinical neurology (110) 110
index medicus (108) 108
male (101) 101
female (99) 99
aged (88) 88
parkinson's disease (82) 82
middle aged (79) 79
dementia (48) 48
neurosciences (41) 41
parkinson disease - complications (36) 36
neuropsychological tests (32) 32
parkinsons disease (32) 32
neurology (30) 30
parkinson disease - diagnosis (29) 29
aged, 80 and over (26) 26
adult (25) 25
parkinson’s disease (25) 25
alzheimer's disease (24) 24
abridged index medicus (23) 23
alzheimers-disease (23) 23
diagnosis (23) 23
cognition (22) 22
biomarkers (21) 21
cognition disorders - etiology (21) 21
movement disorders (19) 19
parkinson disease - physiopathology (19) 19
parkinson disease - psychology (19) 19
neurodegenerative diseases (18) 18
parkinson disease - drug therapy (18) 18
parkinson disease - genetics (18) 18
pathology (18) 18
severity of illness index (18) 18
alpha-synuclein (17) 17
impairment (17) 17
risk factors (17) 17
cohort studies (16) 16
risk (16) 16
cognitive ability (15) 15
dopamine (15) 15
further section (15) 15
medical research (15) 15
cognition disorders - diagnosis (14) 14
reproducibility of results (14) 14
analysis (13) 13
depression (13) 13
disease progression (13) 13
prevalence (13) 13
brain (12) 12
cross-sectional studies (12) 12
lewy bodies (12) 12
medicine, experimental (12) 12
mental disorders (12) 12
parkinson disease (12) 12
parkinson disease - epidemiology (12) 12
sleep behavior disorder (12) 12
surveys and questionnaires (12) 12
cognitive impairment (11) 11
double-blind method (11) 11
genotype (11) 11
psychiatry (11) 11
association (10) 10
mutation (10) 10
parkinson disease - diagnostic imaging (10) 10
parkinson disease - therapy (10) 10
sensitivity and specificity (10) 10
tau (10) 10
cognition & reasoning (9) 9
dopamine transporter (9) 9
dysfunction (9) 9
neuroimaging (9) 9
parkinson disease - metabolism (9) 9
psychiatric status rating scales (9) 9
quality-of-life (9) 9
research (9) 9
studies (9) 9
treatment outcome (9) 9
alzheimers disease (8) 8
analysis of variance (8) 8
case-control studies (8) 8
clinical trials (8) 8
disease (8) 8
executive function (8) 8
follow-up studies (8) 8
genetics (8) 8
levodopa (8) 8
magnetic resonance imaging (8) 8
medical colleges (8) 8
mental status schedule (8) 8
mild cognitive impairment (8) 8
neurodegeneration (8) 8
patients (8) 8
pet (8) 8
rating-scale (8) 8
subthalamic nucleus (8) 8
age (7) 7
age of onset (7) 7
brain - metabolism (7) 7
brain - pathology (7) 7
care and treatment (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of neurology, ISSN 1531-8249, 2018, Volume 85, Issue 2, pp. 259 - 271
Objective To use digital histology in a large autopsy cohort of Lewy body disorder (LBD) patients with dementia to test the hypotheses that co‐occurring... 
UNIVERSITY-OF-PENNSYLVANIA | NATIONAL INSTITUTE | ALZHEIMERS-DISEASE | IMAGE-ANALYSIS | BODIES | ALPHA-SYNUCLEIN | CLINICAL DIAGNOSTIC-CRITERIA | BRAIN PATHOLOGY | NEUROSCIENCES | CLINICAL NEUROLOGY | PARKINSONS-DISEASE DEMENTIA | NEUROPATHOLOGIC ASSESSMENT | Neocortex - pathology | Entorhinal Cortex - metabolism | Putamen - pathology | Humans | tau Proteins - metabolism | Male | Lewy Body Disease - psychology | Mental Status and Dementia Tests | Alzheimer Disease - pathology | Brain - metabolism | Neocortex - metabolism | Autopsy | Amyloid beta-Peptides - metabolism | Aged, 80 and over | Female | Parkinson Disease - metabolism | Alzheimer Disease - psychology | Parkinson Disease - pathology | Plaque, Amyloid - pathology | Lewy Body Disease - pathology | Parkinson Disease - psychology | Lewy Body Disease - metabolism | Alzheimer Disease - metabolism | Brain - pathology | Aged | Entorhinal Cortex - pathology | alpha-Synuclein - metabolism | Putamen - metabolism | Parkinson's disease | Cognitive ability | Synuclein | Heterogeneity | Histopathology | Cortex (frontal) | Dementia disorders | Amyloid | Alzheimer's disease | Movement disorders | Cortex (temporal) | Temporal lobe | Autopsies | Neurodegenerative diseases | Cortex | Histology | Patients | Putamen | Lewy bodies | Pathology | Cortex (entorhinal) | Tau protein | Correlation analysis | Cognitive tasks | Dementia
Journal Article
PloS one, ISSN 1932-6203, 2017, Volume 12, Issue 5, p. e0175674
...Author(s): Chelsea Caspell-Garcia 1, Tanya Simuni 2, Duygu Tosun-Turgut 3, I-Wei Wu 3, Yu Zhang 3, Mike Nalls 4, Andrew Singleton 4, Leslie A. Shaw 5, Ju-Hee... 
INITIATIVE PPMI | DEMENTIA | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | INCIDENT | DISORDER | POLYMORPHISM | DIAGNOSTIC-CRITERIA | PLANNING ABILITY | LEWY BODIES | DECLINE | Brain-Derived Neurotrophic Factor - genetics | Dopamine Plasma Membrane Transport Proteins - metabolism | Parkinson Disease - complications | Humans | Middle Aged | Tomography, Emission-Computed, Single-Photon | Male | tau Proteins - cerebrospinal fluid | Cognitive Dysfunction - cerebrospinal fluid | Catechol O-Methyltransferase - genetics | Diffusion Tensor Imaging | Magnetic Resonance Imaging | Cognitive Dysfunction - epidemiology | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Adult | Cognitive Dysfunction - genetics | Female | Aged | Polymorphism, Single Nucleotide | Biomarkers - cerebrospinal fluid | Cognitive Dysfunction - diagnostic imaging | Complications and side effects | Care and treatment | Parkinson's disease | Development and progression | Cognition disorders | Biological markers | Identification and classification | Brain | Visual cortex | Cognitive ability | Nervous system | Cerebrospinal fluid | Risk factors | Eye | Design | Computed tomography | Education | Aging | Alzheimer's disease | Public health | Movement disorders | Deoxyribonucleic acid--DNA | Apolipoprotein E4 | Emotional behavior | Temporal lobe | Neurodegenerative diseases | Catechol | Single photon emission computed tomography | Substrates | Neurology | Pathology | Thinning | Experimental design | Biomarkers | β-Amyloid | Dementia | Neuroimaging | Haplotypes | Mental disorders | Laboratories | Parkinsons disease | Visual perception | Atrophy | Dementia disorders | Dopamine | Review boards | Health risks | Pharmacology | Dentistry | Medicine | Brain research | Sleep | Brain-derived neurotrophic factor | Magnetic resonance imaging | Parietal lobe | Alzheimers disease | Psychiatry | Polymorphism | Deoxyribonucleic acid | DNA
Journal Article
by Beal, M. Flint and Oakes, David and Shoulson, Ira and Henchcliffe, Claire and Galpern, Wendy R and Haas, Richard and Juncos, Jorge L and Nutt, John G and Voss, Tiffini Smith and Ravina, Bernard and Shults, Clifford M and Helles, Karen and Snively, Victoria and Lew, Mark F and Griebner, Brian and Watts, Arthur and Gao, Shan and Pourcher, Emmanuelle and Bond, Louisette and Kompoliti, Katie and Agarwal, Pinky and Sia, Cherissa and Jog, Mandar and Cole, Linda and Sultana, Munira and Kurlan, Roger and Richard, Irene and Deeley, Cheryl and Waters, Cheryl H and Figueroa, Angel and Arkun, Ani and Brodsky, Matthew and Ondo, William G and Hunter, Christine B and Jimenez-Shahed, Joohi and Palao, Alicia and Miyasaki, Janis M and So, Julie and Tetrud, James and Reys, Liza and Smith, Katharine and Singer, Carlos and Blenke, Anita and Russell, David S and Cotto, Candace and Friedman, Joseph H and Lannon, Margaret and Zhang, Lin and Drasby, Edward and Kumar, Rajeev and Subramanian, Thyagarajan and Ford, Donna Stuppy and Grimes, David A and Cote, Diane and Conway, Jennifer and Siderowf, Andrew D and Evatt, Marian Leslie and Sommerfeld, Barbara and Lieberman, Abraham N and Okun, Michael S and Rodriguez, Ramon L and Merritt, Stacy and Swartz, Camille Louise and Martin, W. R. Wayne and King, Pamela and Stover, Natividad and Guthrie, Stephanie and Watts, Ray L and Ahmed, Anwar and Fernandez, Hubert H and Winters, Adrienna and Mari, Zoltan and Dawson, Ted M and Dunlop, Becky and Feigin, Andrew S and Shannon, Barbara and Nirenberg, Melissa Jill and Ogg, Mattson and Ellias, Samuel A and Thomas, Cathi-Ann and Frei, Karen and Bodis-Wollner, Ivan and Glazman, Sofya and Mayer, Thomas and Hauser, Robert A and Pahwa, Rajesh and Langhammer, April and Ranawaya, Ranjit and Derwent, Lorelei and Sethi, Kapil D and Farrow, Buff and Prakash, Rajan and Litvan, Irene and Robinson, Annette and Sahay, Alok and Gartner, Maureen and Hinson, Vanessa K and Markind, Samuel and Pelikan, Melisa and Perlmutter, Joel S and ... and Parkinson Study Group QE3 Investigators and The Parkinson Study Group QE3 Investigators
JAMA neurology, ISSN 2168-6149, 05/2014, Volume 71, Issue 5, pp. 543 - 552
Journal Article
Movement disorders, ISSN 0885-3185, 2015, Volume 30, Issue 7, pp. 919 - 927
This study was undertaken to determine the prevalence and correlates of cognitive impairment (CI) and neuropsychiatric symptoms (NPS) in early, untreated... 
impulse control disorder | anxiety | Parkinson's disease | cognition | depression | apathy | psychosis | Apathy | Psychosis | Impulse control disorder | Depression | Anxiety | Cognition | DEMENTIA | IMPULSE CONTROL DISORDERS | INCIDENT | CLINICAL NEUROLOGY | IMPAIRMENT | MOTOR SUBTYPE | NONMOTOR SYMPTOMS | COHORT | SPECTRUM | RATING-SCALE | Depression - physiopathology | Prevalence | Humans | Middle Aged | Disruptive, Impulse Control, and Conduct Disorders - etiology | Male | Depression - etiology | Psychotic Disorders - physiopathology | Apathy - physiology | Cognition Disorders - etiology | Cognitive Dysfunction - epidemiology | Aged, 80 and over | Anxiety - epidemiology | Parkinson Disease - epidemiology | Adult | Female | Mental Disorders - etiology | Severity of Illness Index | Parkinson Disease - complications | Cognition Disorders - physiopathology | Depression - epidemiology | Mental Disorders - epidemiology | Anxiety - physiopathology | Psychotic Disorders - epidemiology | Cognitive Dysfunction - etiology | Cognitive Dysfunction - physiopathology | Parkinson Disease - physiopathology | Mental Disorders - physiopathology | Disruptive, Impulse Control, and Conduct Disorders - physiopathology | Disruptive, Impulse Control, and Conduct Disorders - epidemiology | Biomarkers | Aged | Cognition Disorders - epidemiology | Anxiety - etiology | Psychotic Disorders - etiology | Somatotropin | Batteries | Depression, Mental | Prevalence studies (Epidemiology) | Parkinson’s disease
Journal Article
Lancet neurology, ISSN 1474-4422, 2013, Volume 12, Issue 5, pp. 514 - 524
Summary Recent findings question our present understanding of Parkinson's disease and suggest that new research criteria for the diagnosis of Parkinson's... 
Neurology | NEURODEGENERATIVE DISEASE | OLFACTORY DYSFUNCTION | CLINICAL-DIAGNOSIS | LRRK2 G2019S MUTATION | TRANSCRANIAL SONOGRAPHY | LEWY BODY DISEASE | ALPHA-SYNUCLEIN | SUBSTANTIA-NIGRA | CLINICAL NEUROLOGY | SLEEP BEHAVIOR DISORDER | REM-SLEEP | Parkinson Disease - diagnosis | Parkinson Disease - pathology | Research | Humans
Journal Article
Journal Article
Brain (London, England : 1878), ISSN 1460-2156, 2017, Volume 140, Issue 3, pp. aww334 - 763
Journal Article